Eurofins Scientific, the global leader in bio-analysis, has priced a €600m (US$634m) seven-year senior unsecured bond to repurchase outstanding notes. The Baa3/ BBB (Moody’s/Fitch) pays an annual 4% coupon and…
Eurofins Scientific, the global leader in bio-analysis, has priced a €600m (US$634m) seven-year senior unsecured bond to repurchase outstanding notes. The Baa3/ BBB (Moody’s/Fitch) pays an annual 4% coupon and…
…
Rankings & Reports
M&A
Equity
Healthcare Investing Review
Healthcare Real Assets Report
Resources & Events
Resource Hub
Sector Events
Private Capital Conference
Real Assets Conference